SGD Pharma News

News

13 Assets

SGD Pharma awarded the Palme d'Or Internationale du Comité de France 2026

SGD Pharma was honored to receive the Palme d’Or Internationale du Comité de France, together with a Diplôme d’Honneur, during an official ceremony held on January 21, 2026, at the Luxembourg Palace, organized by the Comité de France in partnership with Le Journal du Parlement.

04 Feb 26

SGD Pharma Beauty & Care Division Introduces Eclipse, an Eco-Designed, Refillable Packaging Solution

We proudly announce the launch of our latest sustainable innovation, Eclipse, an eco-designed, refillable packaging solution for the Beauty industry. With an innovative Twist & Lock system joining two separate containers together, Eclipse offers consumers an effortless replacement and recycling experience.

04 Nov 22

SGD Pharma expands cosmetics glass packaging offering, appoints industry leader

Worldwide glass packaging supplier SGD Pharma has announced the expansion of its cosmetics offering globally, appointing industry leader Sheherazade Chamlou, with over 25 years’ experience in the cosmetics packaging industry.

18 Jul 22

SGD Pharma launches industry first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology

Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products. The addition of 100 ml molded glass vials to the Sterinity platform is pioneering, with SGD Pharma being the first global molded glass manufacturing company to offer this size of solution in the RTU market.

03 Mar 22

SGD Pharma speeds up time to market with industry first Ready-to-Use Nest & Tub packaging solution for molded glass vials

Increased demand for parenteral drugs generated by the Covid-19 pandemic has resulted in additional pressures being placed on biopharmaceutical companies to accelerate their time-to-market. This new RTU primary and secondary packaging combination from SGD Pharma offers biopharmaceutical producers the flexibility they need to deliver innovative medicines to patients significantly faster.

18 Jun 21

SGD Pharma breaks new ground with a range of premium containers for medicinal food products

SGD Pharma is expanding its offering to include premium products for the Asian markets – with Phoenix, a new range of high-quality glass containers. The range, which is manufactured in China to international standards, offers a range of possibilities for customised decorations.

01 Oct 18

SGD Pharma shortlisted for the CPhI Pharma Awards

We are thrilled to announce that SGD Pharma has been shortlisted as a finalist in the Packaging category for the CPhI Pharma Awards 2018. The Awards celebrate thinkers and creators breaking new ground and strongly advocate companies committed to driving the industry forward.

24 Sep 18

SGD Pharma introduces Clareo, its new premium range of molded glass vials in Type II, for injectable solutions

Clareo vials from SGD Pharma offer a combination of homogeneous wall thickness and superior cosmetic quality, which for molded glass Type II is unique in the market. The new range offers technical characteristics similar to the vials in the existing range and can replace them without any regulatory change.

29 Aug 18

SGD Pharma upgrades its Chinese plant toward an automated and improved production

SGD Pharma's Zhanjiang (China) plant produces 1.2 million Type II & III flint molded glass vials daily for the parenteral market and for health care beauty products. With a surface of 85,000m2, the plant included a glass furnace, 6 production lines, an ISO 8 clean room of 2000m2, a resorting room and a customization workshop. In early 2018, SGD Pharma invested 7 million Euros to improve the automation and the production, including the rebuilding of the furnace, to make the plant an exemplary production center.

01 May 18

SGD Pharma presents its range of ecological neutral glass bottles

SGD Pharma's baby bottle range has been specifically designed for parents who wish to feed their infants in a healthy manner. SGD Pharma baby bottles are neutral, safe and meet the health and safety regulations for food safety and hygiene. The baby bottles are manufactured in type I glass, which is known as borosilicate glass or neutral glass. They are guaranteed BPA free and without risk of migration.

22 Mar 18

High-precision management for blood derivative products

Drugs made from blood plasma, blood derivative products are used in the treatment of numerous diseases, such as hemophilia or immunodeficiency. Their use is often associated with life threatening situations. Involved in this sector for the past twenty years, SGD Pharma has worked with the main companies and thus developed a high-level expertise to manufacture over 100 million vials specifically dedicated to these derivatives each year.

12 Aug 16

An interview with Dr Karl Leitner, head of production, Octapharma

Octapharma’s core business is the development, production and sale of safe and effective medicines derived from human proteins in the following areas: Haematology (coagulation disorders), Immunotherapy (immune disorders), Intensive Care and Emergency Medicine. Octapharma is an independent, Swiss based company founded in 1983. With over 4,000 employees, Octapharma currently makes sales in over 80 countries.

12 Aug 16

JIC enters into exclusive discussions with Oaktree to acquire SGD Pharma

China Jianyin Investment Ltd. (“JIC”), a long-term investor, enters into exclusive discussions with Oaktree to acquire SGD Pharma. SGD Pharma, a company owned by funds controlled by Oaktree, is a global leading producer of primary glass packaging for the pharmaceutical industry.

17 May 16

Marine Silarbi
News App
English
Created 12 Aug 2016
Modified 12 Aug 2016
Hits 2071

SGD Pharma

Public

If this is your company, CONTACT US to activate Packbase™ software to build your portal.

SGD Pharma News

News